Drug Discovery Outsourcing

World Market Report

MCP21667

EXECUTIVE ENGAGEMENTS

POOL

602
Number of executives repeatedly engaged by snail & email outreach

INTERACTIONS

122
Interactions with Platform & by Email

PARTICIPANTS

24
Unique # Participated

VALIDATIONS

12
Responses Validated*

COMPANIES

33
Responses Validated*
* Login for a full stack data experience

DATE

OCT 2022

TABLES

22

PAGES

89

EDITION

4

PRICE

USD 5600

CODE

MCP21667


COMPETITIVE METRICS

COMPETITORS (ALPHABETICAL)

RANK

(S/A/N/T)

%

VALIDATED RESEARCH *

* S = Strong; A = Active; N = Niche; T= Trivial (<1%)
* Login to Participate & View Data Stacks
* Participating executives must be from a competitive company. Executive credentials are validated by a one-time two-factor authentication, in compliance with GDPR guidelines. Verified executives have complimentary access to our proprietary MarketGlassTM platform and relevant data silos including Trend Data; Brand/IP/TM Feeds; and Market Size, Share & Rank Clusters. Qualified influencers are also invited to join our Expert Panels. Privileges include purchase credits, and collaborative bespoke builds.
View All Companies...

PARTICIPATE NOW!
RESEARCH MODULES EXECUTIVES
  

HIGHLIGHTS & REPORT INDEX

What's New for 2022?

» Global competitiveness and key competitor percentage market shares
» Market presence across multiple geographies - Strong/Active/Niche/Trivial
» Online interactive peer-to-peer collaborative bespoke updates
» Access to our digital archives and MarketGlass Research Platform
» Complimentary updates for one year

Global Drug Discovery Outsourcing Market to Reach $5.4 Billion by 2027
In the changed post COVID-19 business landscape, the global market for Drug Discovery Outsourcing estimated at US$3.5 Billion in the year 2020, is projected to reach a revised size of US$5.4 Billion by 2027, growing at a CAGR of 6.1% over the analysis period 2020-2027. Lead Identification & Candidate Optimization, one of the segments analyzed in the report, is projected to record a 8% CAGR and reach US$2.3 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Preclinical Development segment is readjusted to a revised 5.4% CAGR for the next 7-year period.

The U.S. Market is Estimated at $964.8 Million, While China is Forecast to Grow at 10.2% CAGR
The Drug Discovery Outsourcing market in the U.S. is estimated at US$964.8 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.2 Billion by the year 2027 trailing a CAGR of 10.4% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.7% and 5.4% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.5% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$726.5 Million by the year 2027.



Target Validation & Functional Informatics Segment to Record 4.5% CAGR
In the global Target Validation & Functional Informatics segment, USA, Canada, Japan, China and Europe will drive the 4.5% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$479.9 Million in the year 2020 will reach a projected size of US$630.3 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Latin America will expand at a 5.7% CAGR through the analysis period.

SELECT PLAYERS

Albany Molecular Research, Inc.; Aptuit LLC; Charles River; Dalton Pharma Services; DiscoverX Corporation; Domainex; EVOTEC; GenScript; Jubilant Biosys; LabCorp; Merck & Co., Inc.; Oncodesign; PPD, Inc.; QIAGEN; QuintilesIMS; Selcia Ltd.; Sigma-Aldrich Co. LLC; TGS Lifesciences Pvt Ltd.; Thermo Fisher Scientific, Inc.; Viva Biotech Ltd.; WIL Research; WuXi AppTec

SEGMENTS

» Workflow (Lead Identification & Candidate Optimization, Preclinical Development, Target Validation & Functional Informatics, Target Identification & Screening, Other Workflows) » Therapeutic Area (Respiratory System, Pain & Anesthesia, Oncology, Ophthalmology, Hematology, Cardiovascular, Endocrine, Gastrointestinal, Anti-Infective, Other Therapeutic Areas) » Drug Type (Small Molecules, Large Molecules (Biopharmaceuticals))

GEOGRAPHIES

» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » Spain » Russia » and Rest of Europe » Asia-Pacific » Australia » India » South Korea » and Rest of Asia-Pacific » Latin America » Argentina » Brazil » Mexico » and Rest of Latin America » Middle East » Iran » Israel » Saudi Arabia » United Arab Emirates » and Rest of Middle East » and Africa

TABLE OF CONTENTS

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
Drug Discovery Outsourcing – Global Key Competitors Percentage Market Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
World Recent Past, Current & Future Analysis for Drug Discovery Outsourcing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Drug Discovery Outsourcing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Drug Discovery Outsourcing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Lead Identification & Candidate Optimization by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Lead Identification & Candidate Optimization by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Lead Identification & Candidate Optimization by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Preclinical Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Preclinical Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Preclinical Development by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Target Validation & Functional Informatics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Target Validation & Functional Informatics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Target Validation & Functional Informatics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Target Identification & Screening by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Target Identification & Screening by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Target Identification & Screening by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Other Workflows by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Other Workflows by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Other Workflows by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Hematology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Hematology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Hematology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Cardiovascular by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Cardiovascular by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Cardiovascular by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Endocrine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Endocrine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Endocrine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Gastrointestinal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Gastrointestinal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Gastrointestinal by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Anti-Infective by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Anti-Infective by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Anti-Infective by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Other Therapeutic Areas by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Other Therapeutic Areas by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Other Therapeutic Areas by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Respiratory System by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Respiratory System by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Respiratory System by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Pain & Anesthesia by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Pain & Anesthesia by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Pain & Anesthesia by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Ophthalmology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Ophthalmology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Ophthalmology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Small Molecules by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Small Molecules by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Small Molecules by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Large Molecules (Biopharmaceuticals) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Large Molecules (Biopharmaceuticals) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Large Molecules (Biopharmaceuticals) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
World Drug Discovery Outsourcing Market Analysis of Annual Sales in US$ Million for Years 2012 through 2027
UNITED STATES
Drug Discovery Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2022 (E)
USA Recent Past, Current & Future Analysis for Drug Discovery Outsourcing by Workflow - Lead Identification & Candidate Optimization, Preclinical Development, Target Validation & Functional Informatics, Target Identification & Screening and Other Workflows - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
USA Historic Review for Drug Discovery Outsourcing by Workflow - Lead Identification & Candidate Optimization, Preclinical Development, Target Validation & Functional Informatics, Target Identification & Screening and Other Workflows Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for Drug Discovery Outsourcing by Workflow - Percentage Breakdown of Value Sales for Lead Identification & Candidate Optimization, Preclinical Development, Target Validation & Functional Informatics, Target Identification & Screening and Other Workflows for the Years 2012, 2021 & 2027
USA Recent Past, Current & Future Analysis for Drug Discovery Outsourcing by Therapeutic Area - Hematology, Cardiovascular, Endocrine, Gastrointestinal, Anti-Infective, Other Therapeutic Areas, Respiratory System, Pain & Anesthesia, Oncology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
USA Historic Review for Drug Discovery Outsourcing by Therapeutic Area - Hematology, Cardiovascular, Endocrine, Gastrointestinal, Anti-Infective, Other Therapeutic Areas, Respiratory System, Pain & Anesthesia, Oncology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for Drug Discovery Outsourcing by Therapeutic Area - Percentage Breakdown of Value Sales for Hematology, Cardiovascular, Endocrine, Gastrointestinal, Anti-Infective, Other Therapeutic Areas, Respiratory System, Pain & Anesthesia, Oncology and Ophthalmology for the Years 2012, 2021 & 2027
USA Recent Past, Current & Future Analysis for Drug Discovery Outsourcing by Drug Type - Small Molecules and Large Molecules (Biopharmaceuticals) - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
USA Historic Review for Drug Discovery Outsourcing by Drug Type - Small Molecules and Large Molecules (Biopharmaceuticals) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for Drug Discovery Outsourcing by Drug Type - Percentage Breakdown of Value Sales for Small Molecules and Large Molecules (Biopharmaceuticals) for the Years 2012, 2021 & 2027
CANADA
Canada Recent Past, Current & Future Analysis for Drug Discovery Outsourcing by Workflow - Lead Identification & Candidate Optimization, Preclinical Development, Target Validation & Functional Informatics, Target Identification & Screening and Other Workflows - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Drug Discovery Outsourcing by Workflow - Lead Identification & Candidate Optimization, Preclinical Development, Target Validation & Functional Informatics, Target Identification & Screening and Other Workflows Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for Drug Discovery Outsourcing by Workflow - Percentage Breakdown of Value Sales for Lead Identification & Candidate Optimization, Preclinical Development, Target Validation & Functional Informatics, Target Identification & Screening and Other Workflows for the Years 2012, 2021 & 2027
Canada Recent Past, Current & Future Analysis for Drug Discovery Outsourcing by Therapeutic Area - Hematology, Cardiovascular, Endocrine, Gastrointestinal, Anti-Infective, Other Therapeutic Areas, Respiratory System, Pain & Anesthesia, Oncology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Drug Discovery Outsourcing by Therapeutic Area - Hematology, Cardiovascular, Endocrine, Gastrointestinal, Anti-Infective, Other Therapeutic Areas, Respiratory System, Pain & Anesthesia, Oncology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for Drug Discovery Outsourcing by Therapeutic Area - Percentage Breakdown of Value Sales for Hematology, Cardiovascular, Endocrine, Gastrointestinal, Anti-Infective, Other Therapeutic Areas, Respiratory System, Pain & Anesthesia, Oncology and Ophthalmology for the Years 2012, 2021 & 2027
Canada Recent Past, Current & Future Analysis for Drug Discovery Outsourcing by Drug Type - Small Molecules and Large Molecules (Biopharmaceuticals) - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Drug Discovery Outsourcing by Drug Type - Small Molecules and Large Molecules (Biopharmaceuticals) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for Drug Discovery Outsourcing by Drug Type - Percentage Breakdown of Value Sales for Small Molecules and Large Molecules (Biopharmaceuticals) for the Years 2012, 2021 & 2027
JAPAN
Drug Discovery Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2022 (E)
Japan Recent Past, Current & Future Analysis for Drug Discovery Outsourcing by Workflow - Lead Identification & Candidate Optimization, Preclinical Development, Target Validation & Functional Informatics, Target Identification & Screening and Other Workflows - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Drug Discovery Outsourcing by Workflow - Lead Identification & Candidate Optimization, Preclinical Development, Target Validation & Functional Informatics, Target Identification & Screening and Other Workflows Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for Drug Discovery Outsourcing by Workflow - Percentage Breakdown of Value Sales for Lead Identification & Candidate Optimization, Preclinical Development, Target Validation & Functional Informatics, Target Identification & Screening and Other Workflows for the Years 2012, 2021 & 2027
Japan Recent Past, Current & Future Analysis for Drug Discovery Outsourcing by Therapeutic Area - Hematology, Cardiovascular, Endocrine, Gastrointestinal, Anti-Infective, Other Therapeutic Areas, Respiratory System, Pain & Anesthesia, Oncology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Drug Discovery Outsourcing by Therapeutic Area - Hematology, Cardiovascular, Endocrine, Gastrointestinal, Anti-Infective, Other Therapeutic Areas, Respiratory System, Pain & Anesthesia, Oncology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for Drug Discovery Outsourcing by Therapeutic Area - Percentage Breakdown of Value Sales for Hematology, Cardiovascular, Endocrine, Gastrointestinal, Anti-Infective, Other Therapeutic Areas, Respiratory System, Pain & Anesthesia, Oncology and Ophthalmology for the Years 2012, 2021 & 2027
Japan Recent Past, Current & Future Analysis for Drug Discovery Outsourcing by Drug Type - Small Molecules and Large Molecules (Biopharmaceuticals) - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Drug Discovery Outsourcing by Drug Type - Small Molecules and Large Molecules (Biopharmaceuticals) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for Drug Discovery Outsourcing by Drug Type - Percentage Breakdown of Value Sales for Small Molecules and Large Molecules (Biopharmaceuticals) for the Years 2012, 2021 & 2027
CHINA
Drug Discovery Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2022 (E)
China Recent Past, Current & Future Analysis for Drug Discovery Outsourcing by Workflow - Lead Identification & Candidate Optimization, Preclinical Development, Target Validation & Functional Informatics, Target Identification & Screening and Other Workflows - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
China Historic Review for Drug Discovery Outsourcing by Workflow - Lead Identification & Candidate Optimization, Preclinical Development, Target Validation & Functional Informatics, Target Identification & Screening and Other Workflows Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for Drug Discovery Outsourcing by Workflow - Percentage Breakdown of Value Sales for Lead Identification & Candidate Optimization, Preclinical Development, Target Validation & Functional Informatics, Target Identification & Screening and Other Workflows for the Years 2012, 2021 & 2027
China Recent Past, Current & Future Analysis for Drug Discovery Outsourcing by Therapeutic Area - Hematology, Cardiovascular, Endocrine, Gastrointestinal, Anti-Infective, Other Therapeutic Areas, Respiratory System, Pain & Anesthesia, Oncology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
China Historic Review for Drug Discovery Outsourcing by Therapeutic Area - Hematology, Cardiovascular, Endocrine, Gastrointestinal, Anti-Infective, Other Therapeutic Areas, Respiratory System, Pain & Anesthesia, Oncology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for Drug Discovery Outsourcing by Therapeutic Area - Percentage Breakdown of Value Sales for Hematology, Cardiovascular, Endocrine, Gastrointestinal, Anti-Infective, Other Therapeutic Areas, Respiratory System, Pain & Anesthesia, Oncology and Ophthalmology for the Years 2012, 2021 & 2027
China Recent Past, Current & Future Analysis for Drug Discovery Outsourcing by Drug Type - Small Molecules and Large Molecules (Biopharmaceuticals) - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
China Historic Review for Drug Discovery Outsourcing by Drug Type - Small Molecules and Large Molecules (Biopharmaceuticals) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for Drug Discovery Outsourcing by Drug Type - Percentage Breakdown of Value Sales for Small Molecules and Large Molecules (Biopharmaceuticals) for the Years 2012, 2021 & 2027
EUROPE
Drug Discovery Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2022 (E)
Europe Recent Past, Current & Future Analysis for Drug Discovery Outsourcing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
Europe Historic Review for Drug Discovery Outsourcing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Drug Discovery Outsourcing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2021 & 2027
Europe Recent Past, Current & Future Analysis for Drug Discovery Outsourcing by Workflow - Lead Identification & Candidate Optimization, Preclinical Development, Target Validation & Functional Informatics, Target Identification & Screening and Other Workflows - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Europe Historic Review for Drug Discovery Outsourcing by Workflow - Lead Identification & Candidate Optimization, Preclinical Development, Target Validation & Functional Informatics, Target Identification & Screening and Other Workflows Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Drug Discovery Outsourcing by Workflow - Percentage Breakdown of Value Sales for Lead Identification & Candidate Optimization, Preclinical Development, Target Validation & Functional Informatics, Target Identification & Screening and Other Workflows for the Years 2012, 2021 & 2027
Europe Recent Past, Current & Future Analysis for Drug Discovery Outsourcing by Therapeutic Area - Hematology, Cardiovascular, Endocrine, Gastrointestinal, Anti-Infective, Other Therapeutic Areas, Respiratory System, Pain & Anesthesia, Oncology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Europe Historic Review for Drug Discovery Outsourcing by Therapeutic Area - Hematology, Cardiovascular, Endocrine, Gastrointestinal, Anti-Infective, Other Therapeutic Areas, Respiratory System, Pain & Anesthesia, Oncology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Drug Discovery Outsourcing by Therapeutic Area - Percentage Breakdown of Value Sales for Hematology, Cardiovascular, Endocrine, Gastrointestinal, Anti-Infective, Other Therapeutic Areas, Respiratory System, Pain & Anesthesia, Oncology and Ophthalmology for the Years 2012, 2021 & 2027
Europe Recent Past, Current & Future Analysis for Drug Discovery Outsourcing by Drug Type - Small Molecules and Large Molecules (Biopharmaceuticals) - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Europe Historic Review for Drug Discovery Outsourcing by Drug Type - Small Molecules and Large Molecules (Biopharmaceuticals) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Drug Discovery Outsourcing by Drug Type - Percentage Breakdown of Value Sales for Small Molecules and Large Molecules (Biopharmaceuticals) for the Years 2012, 2021 & 2027
FRANCE
Drug Discovery Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2022 (E)
France Recent Past, Current & Future Analysis for Drug Discovery Outsourcing by Workflow - Lead Identification & Candidate Optimization, Preclinical Development, Target Validation & Functional Informatics, Target Identification & Screening and Other Workflows - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
France Historic Review for Drug Discovery Outsourcing by Workflow - Lead Identification & Candidate Optimization, Preclinical Development, Target Validation & Functional Informatics, Target Identification & Screening and Other Workflows Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for Drug Discovery Outsourcing by Workflow - Percentage Breakdown of Value Sales for Lead Identification & Candidate Optimization, Preclinical Development, Target Validation & Functional Informatics, Target Identification & Screening and Other Workflows for the Years 2012, 2021 & 2027
France Recent Past, Current & Future Analysis for Drug Discovery Outsourcing by Therapeutic Area - Hematology, Cardiovascular, Endocrine, Gastrointestinal, Anti-Infective, Other Therapeutic Areas, Respiratory System, Pain & Anesthesia, Oncology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
France Historic Review for Drug Discovery Outsourcing by Therapeutic Area - Hematology, Cardiovascular, Endocrine, Gastrointestinal, Anti-Infective, Other Therapeutic Areas, Respiratory System, Pain & Anesthesia, Oncology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for Drug Discovery Outsourcing by Therapeutic Area - Percentage Breakdown of Value Sales for Hematology, Cardiovascular, Endocrine, Gastrointestinal, Anti-Infective, Other Therapeutic Areas, Respiratory System, Pain & Anesthesia, Oncology and Ophthalmology for the Years 2012, 2021 & 2027
France Recent Past, Current & Future Analysis for Drug Discovery Outsourcing by Drug Type - Small Molecules and Large Molecules (Biopharmaceuticals) - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
France Historic Review for Drug Discovery Outsourcing by Drug Type - Small Molecules and Large Molecules (Biopharmaceuticals) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for Drug Discovery Outsourcing by Drug Type - Percentage Breakdown of Value Sales for Small Molecules and Large Molecules (Biopharmaceuticals) for the Years 2012, 2021 & 2027
GERMANY
Drug Discovery Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2022 (E)
Germany Recent Past, Current & Future Analysis for Drug Discovery Outsourcing by Workflow - Lead Identification & Candidate Optimization, Preclinical Development, Target Validation & Functional Informatics, Target Identification & Screening and Other Workflows - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Drug Discovery Outsourcing by Workflow - Lead Identification & Candidate Optimization, Preclinical Development, Target Validation & Functional Informatics, Target Identification & Screening and Other Workflows Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for Drug Discovery Outsourcing by Workflow - Percentage Breakdown of Value Sales for Lead Identification & Candidate Optimization, Preclinical Development, Target Validation & Functional Informatics, Target Identification & Screening and Other Workflows for the Years 2012, 2021 & 2027
Germany Recent Past, Current & Future Analysis for Drug Discovery Outsourcing by Therapeutic Area - Hematology, Cardiovascular, Endocrine, Gastrointestinal, Anti-Infective, Other Therapeutic Areas, Respiratory System, Pain & Anesthesia, Oncology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Drug Discovery Outsourcing by Therapeutic Area - Hematology, Cardiovascular, Endocrine, Gastrointestinal, Anti-Infective, Other Therapeutic Areas, Respiratory System, Pain & Anesthesia, Oncology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for Drug Discovery Outsourcing by Therapeutic Area - Percentage Breakdown of Value Sales for Hematology, Cardiovascular, Endocrine, Gastrointestinal, Anti-Infective, Other Therapeutic Areas, Respiratory System, Pain & Anesthesia, Oncology and Ophthalmology for the Years 2012, 2021 & 2027
Germany Recent Past, Current & Future Analysis for Drug Discovery Outsourcing by Drug Type - Small Molecules and Large Molecules (Biopharmaceuticals) - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Drug Discovery Outsourcing by Drug Type - Small Molecules and Large Molecules (Biopharmaceuticals) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for Drug Discovery Outsourcing by Drug Type - Percentage Breakdown of Value Sales for Small Molecules and Large Molecules (Biopharmaceuticals) for the Years 2012, 2021 & 2027
ITALY
Italy Recent Past, Current & Future Analysis for Drug Discovery Outsourcing by Workflow - Lead Identification & Candidate Optimization, Preclinical Development, Target Validation & Functional Informatics, Target Identification & Screening and Other Workflows - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Drug Discovery Outsourcing by Workflow - Lead Identification & Candidate Optimization, Preclinical Development, Target Validation & Functional Informatics, Target Identification & Screening and Other Workflows Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for Drug Discovery Outsourcing by Workflow - Percentage Breakdown of Value Sales for Lead Identification & Candidate Optimization, Preclinical Development, Target Validation & Functional Informatics, Target Identification & Screening and Other Workflows for the Years 2012, 2021 & 2027
Italy Recent Past, Current & Future Analysis for Drug Discovery Outsourcing by Therapeutic Area - Hematology, Cardiovascular, Endocrine, Gastrointestinal, Anti-Infective, Other Therapeutic Areas, Respiratory System, Pain & Anesthesia, Oncology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Drug Discovery Outsourcing by Therapeutic Area - Hematology, Cardiovascular, Endocrine, Gastrointestinal, Anti-Infective, Other Therapeutic Areas, Respiratory System, Pain & Anesthesia, Oncology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for Drug Discovery Outsourcing by Therapeutic Area - Percentage Breakdown of Value Sales for Hematology, Cardiovascular, Endocrine, Gastrointestinal, Anti-Infective, Other Therapeutic Areas, Respiratory System, Pain & Anesthesia, Oncology and Ophthalmology for the Years 2012, 2021 & 2027
Italy Recent Past, Current & Future Analysis for Drug Discovery Outsourcing by Drug Type - Small Molecules and Large Molecules (Biopharmaceuticals) - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Drug Discovery Outsourcing by Drug Type - Small Molecules and Large Molecules (Biopharmaceuticals) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for Drug Discovery Outsourcing by Drug Type - Percentage Breakdown of Value Sales for Small Molecules and Large Molecules (Biopharmaceuticals) for the Years 2012, 2021 & 2027
UNITED KINGDOM
Drug Discovery Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2022 (E)
UK Recent Past, Current & Future Analysis for Drug Discovery Outsourcing by Workflow - Lead Identification & Candidate Optimization, Preclinical Development, Target Validation & Functional Informatics, Target Identification & Screening and Other Workflows - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
UK Historic Review for Drug Discovery Outsourcing by Workflow - Lead Identification & Candidate Optimization, Preclinical Development, Target Validation & Functional Informatics, Target Identification & Screening and Other Workflows Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for Drug Discovery Outsourcing by Workflow - Percentage Breakdown of Value Sales for Lead Identification & Candidate Optimization, Preclinical Development, Target Validation & Functional Informatics, Target Identification & Screening and Other Workflows for the Years 2012, 2021 & 2027
UK Recent Past, Current & Future Analysis for Drug Discovery Outsourcing by Therapeutic Area - Hematology, Cardiovascular, Endocrine, Gastrointestinal, Anti-Infective, Other Therapeutic Areas, Respiratory System, Pain & Anesthesia, Oncology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
UK Historic Review for Drug Discovery Outsourcing by Therapeutic Area - Hematology, Cardiovascular, Endocrine, Gastrointestinal, Anti-Infective, Other Therapeutic Areas, Respiratory System, Pain & Anesthesia, Oncology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for Drug Discovery Outsourcing by Therapeutic Area - Percentage Breakdown of Value Sales for Hematology, Cardiovascular, Endocrine, Gastrointestinal, Anti-Infective, Other Therapeutic Areas, Respiratory System, Pain & Anesthesia, Oncology and Ophthalmology for the Years 2012, 2021 & 2027
UK Recent Past, Current & Future Analysis for Drug Discovery Outsourcing by Drug Type - Small Molecules and Large Molecules (Biopharmaceuticals) - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
UK Historic Review for Drug Discovery Outsourcing by Drug Type - Small Molecules and Large Molecules (Biopharmaceuticals) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for Drug Discovery Outsourcing by Drug Type - Percentage Breakdown of Value Sales for Small Molecules and Large Molecules (Biopharmaceuticals) for the Years 2012, 2021 & 2027
SPAIN
Spain Recent Past, Current & Future Analysis for Drug Discovery Outsourcing by Workflow - Lead Identification & Candidate Optimization, Preclinical Development, Target Validation & Functional Informatics, Target Identification & Screening and Other Workflows - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Spain Historic Review for Drug Discovery Outsourcing by Workflow - Lead Identification & Candidate Optimization, Preclinical Development, Target Validation & Functional Informatics, Target Identification & Screening and Other Workflows Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Spain 15-Year Perspective for Drug Discovery Outsourcing by Workflow - Percentage Breakdown of Value Sales for Lead Identification & Candidate Optimization, Preclinical Development, Target Validation & Functional Informatics, Target Identification & Screening and Other Workflows for the Years 2012, 2021 & 2027
Spain Recent Past, Current & Future Analysis for Drug Discovery Outsourcing by Therapeutic Area - Hematology, Cardiovascular, Endocrine, Gastrointestinal, Anti-Infective, Other Therapeutic Areas, Respiratory System, Pain & Anesthesia, Oncology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Spain Historic Review for Drug Discovery Outsourcing by Therapeutic Area - Hematology, Cardiovascular, Endocrine, Gastrointestinal, Anti-Infective, Other Therapeutic Areas, Respiratory System, Pain & Anesthesia, Oncology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Spain 15-Year Perspective for Drug Discovery Outsourcing by Therapeutic Area - Percentage Breakdown of Value Sales for Hematology, Cardiovascular, Endocrine, Gastrointestinal, Anti-Infective, Other Therapeutic Areas, Respiratory System, Pain & Anesthesia, Oncology and Ophthalmology for the Years 2012, 2021 & 2027
Spain Recent Past, Current & Future Analysis for Drug Discovery Outsourcing by Drug Type - Small Molecules and Large Molecules (Biopharmaceuticals) - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Spain Historic Review for Drug Discovery Outsourcing by Drug Type - Small Molecules and Large Molecules (Biopharmaceuticals) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Spain 15-Year Perspective for Drug Discovery Outsourcing by Drug Type - Percentage Breakdown of Value Sales for Small Molecules and Large Molecules (Biopharmaceuticals) for the Years 2012, 2021 & 2027
RUSSIA
Russia Recent Past, Current & Future Analysis for Drug Discovery Outsourcing by Workflow - Lead Identification & Candidate Optimization, Preclinical Development, Target Validation & Functional Informatics, Target Identification & Screening and Other Workflows - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Russia Historic Review for Drug Discovery Outsourcing by Workflow - Lead Identification & Candidate Optimization, Preclinical Development, Target Validation & Functional Informatics, Target Identification & Screening and Other Workflows Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Russia 15-Year Perspective for Drug Discovery Outsourcing by Workflow - Percentage Breakdown of Value Sales for Lead Identification & Candidate Optimization, Preclinical Development, Target Validation & Functional Informatics, Target Identification & Screening and Other Workflows for the Years 2012, 2021 & 2027
Russia Recent Past, Current & Future Analysis for Drug Discovery Outsourcing by Therapeutic Area - Hematology, Cardiovascular, Endocrine, Gastrointestinal, Anti-Infective, Other Therapeutic Areas, Respiratory System, Pain & Anesthesia, Oncology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Russia Historic Review for Drug Discovery Outsourcing by Therapeutic Area - Hematology, Cardiovascular, Endocrine, Gastrointestinal, Anti-Infective, Other Therapeutic Areas, Respiratory System, Pain & Anesthesia, Oncology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Russia 15-Year Perspective for Drug Discovery Outsourcing by Therapeutic Area - Percentage Breakdown of Value Sales for Hematology, Cardiovascular, Endocrine, Gastrointestinal, Anti-Infective, Other Therapeutic Areas, Respiratory System, Pain & Anesthesia, Oncology and Ophthalmology for the Years 2012, 2021 & 2027
Russia Recent Past, Current & Future Analysis for Drug Discovery Outsourcing by Drug Type - Small Molecules and Large Molecules (Biopharmaceuticals) - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Russia Historic Review for Drug Discovery Outsourcing by Drug Type - Small Molecules and Large Molecules (Biopharmaceuticals) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Russia 15-Year Perspective for Drug Discovery Outsourcing by Drug Type - Percentage Breakdown of Value Sales for Small Molecules and Large Molecules (Biopharmaceuticals) for the Years 2012, 2021 & 2027
REST OF EUROPE
Rest of Europe Recent Past, Current & Future Analysis for Drug Discovery Outsourcing by Workflow - Lead Identification & Candidate Optimization, Preclinical Development, Target Validation & Functional Informatics, Target Identification & Screening and Other Workflows - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Drug Discovery Outsourcing by Workflow - Lead Identification & Candidate Optimization, Preclinical Development, Target Validation & Functional Informatics, Target Identification & Screening and Other Workflows Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for Drug Discovery Outsourcing by Workflow - Percentage Breakdown of Value Sales for Lead Identification & Candidate Optimization, Preclinical Development, Target Validation & Functional Informatics, Target Identification & Screening and Other Workflows for the Years 2012, 2021 & 2027
Rest of Europe Recent Past, Current & Future Analysis for Drug Discovery Outsourcing by Therapeutic Area - Hematology, Cardiovascular, Endocrine, Gastrointestinal, Anti-Infective, Other Therapeutic Areas, Respiratory System, Pain & Anesthesia, Oncology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Drug Discovery Outsourcing by Therapeutic Area - Hematology, Cardiovascular, Endocrine, Gastrointestinal, Anti-Infective, Other Therapeutic Areas, Respiratory System, Pain & Anesthesia, Oncology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for Drug Discovery Outsourcing by Therapeutic Area - Percentage Breakdown of Value Sales for Hematology, Cardiovascular, Endocrine, Gastrointestinal, Anti-Infective, Other Therapeutic Areas, Respiratory System, Pain & Anesthesia, Oncology and Ophthalmology for the Years 2012, 2021 & 2027
Rest of Europe Recent Past, Current & Future Analysis for Drug Discovery Outsourcing by Drug Type - Small Molecules and Large Molecules (Biopharmaceuticals) - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Drug Discovery Outsourcing by Drug Type - Small Molecules and Large Molecules (Biopharmaceuticals) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for Drug Discovery Outsourcing by Drug Type - Percentage Breakdown of Value Sales for Small Molecules and Large Molecules (Biopharmaceuticals) for the Years 2012, 2021 & 2027
ASIA-PACIFIC
Drug Discovery Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2022 (E)
Asia-Pacific Recent Past, Current & Future Analysis for Drug Discovery Outsourcing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Drug Discovery Outsourcing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Drug Discovery Outsourcing by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2021 & 2027
Asia-Pacific Recent Past, Current & Future Analysis for Drug Discovery Outsourcing by Workflow - Lead Identification & Candidate Optimization, Preclinical Development, Target Validation & Functional Informatics, Target Identification & Screening and Other Workflows - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Drug Discovery Outsourcing by Workflow - Lead Identification & Candidate Optimization, Preclinical Development, Target Validation & Functional Informatics, Target Identification & Screening and Other Workflows Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Drug Discovery Outsourcing by Workflow - Percentage Breakdown of Value Sales for Lead Identification & Candidate Optimization, Preclinical Development, Target Validation & Functional Informatics, Target Identification & Screening and Other Workflows for the Years 2012, 2021 & 2027
Asia-Pacific Recent Past, Current & Future Analysis for Drug Discovery Outsourcing by Therapeutic Area - Hematology, Cardiovascular, Endocrine, Gastrointestinal, Anti-Infective, Other Therapeutic Areas, Respiratory System, Pain & Anesthesia, Oncology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Drug Discovery Outsourcing by Therapeutic Area - Hematology, Cardiovascular, Endocrine, Gastrointestinal, Anti-Infective, Other Therapeutic Areas, Respiratory System, Pain & Anesthesia, Oncology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Drug Discovery Outsourcing by Therapeutic Area - Percentage Breakdown of Value Sales for Hematology, Cardiovascular, Endocrine, Gastrointestinal, Anti-Infective, Other Therapeutic Areas, Respiratory System, Pain & Anesthesia, Oncology and Ophthalmology for the Years 2012, 2021 & 2027
Asia-Pacific Recent Past, Current & Future Analysis for Drug Discovery Outsourcing by Drug Type - Small Molecules and Large Molecules (Biopharmaceuticals) - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Drug Discovery Outsourcing by Drug Type - Small Molecules and Large Molecules (Biopharmaceuticals) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Drug Discovery Outsourcing by Drug Type - Percentage Breakdown of Value Sales for Small Molecules and Large Molecules (Biopharmaceuticals) for the Years 2012, 2021 & 2027
AUSTRALIA
Drug Discovery Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2022 (E)
Australia Recent Past, Current & Future Analysis for Drug Discovery Outsourcing by Workflow - Lead Identification & Candidate Optimization, Preclinical Development, Target Validation & Functional Informatics, Target Identification & Screening and Other Workflows - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Australia Historic Review for Drug Discovery Outsourcing by Workflow - Lead Identification & Candidate Optimization, Preclinical Development, Target Validation & Functional Informatics, Target Identification & Screening and Other Workflows Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Australia 15-Year Perspective for Drug Discovery Outsourcing by Workflow - Percentage Breakdown of Value Sales for Lead Identification & Candidate Optimization, Preclinical Development, Target Validation & Functional Informatics, Target Identification & Screening and Other Workflows for the Years 2012, 2021 & 2027
Australia Recent Past, Current & Future Analysis for Drug Discovery Outsourcing by Therapeutic Area - Hematology, Cardiovascular, Endocrine, Gastrointestinal, Anti-Infective, Other Therapeutic Areas, Respiratory System, Pain & Anesthesia, Oncology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Australia Historic Review for Drug Discovery Outsourcing by Therapeutic Area - Hematology, Cardiovascular, Endocrine, Gastrointestinal, Anti-Infective, Other Therapeutic Areas, Respiratory System, Pain & Anesthesia, Oncology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Australia 15-Year Perspective for Drug Discovery Outsourcing by Therapeutic Area - Percentage Breakdown of Value Sales for Hematology, Cardiovascular, Endocrine, Gastrointestinal, Anti-Infective, Other Therapeutic Areas, Respiratory System, Pain & Anesthesia, Oncology and Ophthalmology for the Years 2012, 2021 & 2027
Australia Recent Past, Current & Future Analysis for Drug Discovery Outsourcing by Drug Type - Small Molecules and Large Molecules (Biopharmaceuticals) - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Australia Historic Review for Drug Discovery Outsourcing by Drug Type - Small Molecules and Large Molecules (Biopharmaceuticals) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Australia 15-Year Perspective for Drug Discovery Outsourcing by Drug Type - Percentage Breakdown of Value Sales for Small Molecules and Large Molecules (Biopharmaceuticals) for the Years 2012, 2021 & 2027
INDIA
Drug Discovery Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2022 (E)
India Recent Past, Current & Future Analysis for Drug Discovery Outsourcing by Workflow - Lead Identification & Candidate Optimization, Preclinical Development, Target Validation & Functional Informatics, Target Identification & Screening and Other Workflows - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
India Historic Review for Drug Discovery Outsourcing by Workflow - Lead Identification & Candidate Optimization, Preclinical Development, Target Validation & Functional Informatics, Target Identification & Screening and Other Workflows Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
India 15-Year Perspective for Drug Discovery Outsourcing by Workflow - Percentage Breakdown of Value Sales for Lead Identification & Candidate Optimization, Preclinical Development, Target Validation & Functional Informatics, Target Identification & Screening and Other Workflows for the Years 2012, 2021 & 2027
India Recent Past, Current & Future Analysis for Drug Discovery Outsourcing by Therapeutic Area - Hematology, Cardiovascular, Endocrine, Gastrointestinal, Anti-Infective, Other Therapeutic Areas, Respiratory System, Pain & Anesthesia, Oncology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
India Historic Review for Drug Discovery Outsourcing by Therapeutic Area - Hematology, Cardiovascular, Endocrine, Gastrointestinal, Anti-Infective, Other Therapeutic Areas, Respiratory System, Pain & Anesthesia, Oncology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
India 15-Year Perspective for Drug Discovery Outsourcing by Therapeutic Area - Percentage Breakdown of Value Sales for Hematology, Cardiovascular, Endocrine, Gastrointestinal, Anti-Infective, Other Therapeutic Areas, Respiratory System, Pain & Anesthesia, Oncology and Ophthalmology for the Years 2012, 2021 & 2027
India Recent Past, Current & Future Analysis for Drug Discovery Outsourcing by Drug Type - Small Molecules and Large Molecules (Biopharmaceuticals) - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
India Historic Review for Drug Discovery Outsourcing by Drug Type - Small Molecules and Large Molecules (Biopharmaceuticals) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
India 15-Year Perspective for Drug Discovery Outsourcing by Drug Type - Percentage Breakdown of Value Sales for Small Molecules and Large Molecules (Biopharmaceuticals) for the Years 2012, 2021 & 2027
SOUTH KOREA
South Korea Recent Past, Current & Future Analysis for Drug Discovery Outsourcing by Workflow - Lead Identification & Candidate Optimization, Preclinical Development, Target Validation & Functional Informatics, Target Identification & Screening and Other Workflows - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
South Korea Historic Review for Drug Discovery Outsourcing by Workflow - Lead Identification & Candidate Optimization, Preclinical Development, Target Validation & Functional Informatics, Target Identification & Screening and Other Workflows Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
South Korea 15-Year Perspective for Drug Discovery Outsourcing by Workflow - Percentage Breakdown of Value Sales for Lead Identification & Candidate Optimization, Preclinical Development, Target Validation & Functional Informatics, Target Identification & Screening and Other Workflows for the Years 2012, 2021 & 2027
South Korea Recent Past, Current & Future Analysis for Drug Discovery Outsourcing by Therapeutic Area - Hematology, Cardiovascular, Endocrine, Gastrointestinal, Anti-Infective, Other Therapeutic Areas, Respiratory System, Pain & Anesthesia, Oncology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
South Korea Historic Review for Drug Discovery Outsourcing by Therapeutic Area - Hematology, Cardiovascular, Endocrine, Gastrointestinal, Anti-Infective, Other Therapeutic Areas, Respiratory System, Pain & Anesthesia, Oncology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
South Korea 15-Year Perspective for Drug Discovery Outsourcing by Therapeutic Area - Percentage Breakdown of Value Sales for Hematology, Cardiovascular, Endocrine, Gastrointestinal, Anti-Infective, Other Therapeutic Areas, Respiratory System, Pain & Anesthesia, Oncology and Ophthalmology for the Years 2012, 2021 & 2027
South Korea Recent Past, Current & Future Analysis for Drug Discovery Outsourcing by Drug Type - Small Molecules and Large Molecules (Biopharmaceuticals) - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
South Korea Historic Review for Drug Discovery Outsourcing by Drug Type - Small Molecules and Large Molecules (Biopharmaceuticals) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
South Korea 15-Year Perspective for Drug Discovery Outsourcing by Drug Type - Percentage Breakdown of Value Sales for Small Molecules and Large Molecules (Biopharmaceuticals) for the Years 2012, 2021 & 2027
REST OF ASIA-PACIFIC
Rest of Asia-Pacific Recent Past, Current & Future Analysis for Drug Discovery Outsourcing by Workflow - Lead Identification & Candidate Optimization, Preclinical Development, Target Validation & Functional Informatics, Target Identification & Screening and Other Workflows - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Asia-Pacific Historic Review for Drug Discovery Outsourcing by Workflow - Lead Identification & Candidate Optimization, Preclinical Development, Target Validation & Functional Informatics, Target Identification & Screening and Other Workflows Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of Asia-Pacific 15-Year Perspective for Drug Discovery Outsourcing by Workflow - Percentage Breakdown of Value Sales for Lead Identification & Candidate Optimization, Preclinical Development, Target Validation & Functional Informatics, Target Identification & Screening and Other Workflows for the Years 2012, 2021 & 2027
Rest of Asia-Pacific Recent Past, Current & Future Analysis for Drug Discovery Outsourcing by Therapeutic Area - Hematology, Cardiovascular, Endocrine, Gastrointestinal, Anti-Infective, Other Therapeutic Areas, Respiratory System, Pain & Anesthesia, Oncology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Asia-Pacific Historic Review for Drug Discovery Outsourcing by Therapeutic Area - Hematology, Cardiovascular, Endocrine, Gastrointestinal, Anti-Infective, Other Therapeutic Areas, Respiratory System, Pain & Anesthesia, Oncology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of Asia-Pacific 15-Year Perspective for Drug Discovery Outsourcing by Therapeutic Area - Percentage Breakdown of Value Sales for Hematology, Cardiovascular, Endocrine, Gastrointestinal, Anti-Infective, Other Therapeutic Areas, Respiratory System, Pain & Anesthesia, Oncology and Ophthalmology for the Years 2012, 2021 & 2027
Rest of Asia-Pacific Recent Past, Current & Future Analysis for Drug Discovery Outsourcing by Drug Type - Small Molecules and Large Molecules (Biopharmaceuticals) - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Asia-Pacific Historic Review for Drug Discovery Outsourcing by Drug Type - Small Molecules and Large Molecules (Biopharmaceuticals) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of Asia-Pacific 15-Year Perspective for Drug Discovery Outsourcing by Drug Type - Percentage Breakdown of Value Sales for Small Molecules and Large Molecules (Biopharmaceuticals) for the Years 2012, 2021 & 2027
LATIN AMERICA
Drug Discovery Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2022 (E)
Latin America Recent Past, Current & Future Analysis for Drug Discovery Outsourcing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
Latin America Historic Review for Drug Discovery Outsourcing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Latin America 15-Year Perspective for Drug Discovery Outsourcing by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2012, 2021 & 2027
Latin America Recent Past, Current & Future Analysis for Drug Discovery Outsourcing by Workflow - Lead Identification & Candidate Optimization, Preclinical Development, Target Validation & Functional Informatics, Target Identification & Screening and Other Workflows - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Latin America Historic Review for Drug Discovery Outsourcing by Workflow - Lead Identification & Candidate Optimization, Preclinical Development, Target Validation & Functional Informatics, Target Identification & Screening and Other Workflows Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Latin America 15-Year Perspective for Drug Discovery Outsourcing by Workflow - Percentage Breakdown of Value Sales for Lead Identification & Candidate Optimization, Preclinical Development, Target Validation & Functional Informatics, Target Identification & Screening and Other Workflows for the Years 2012, 2021 & 2027
Latin America Recent Past, Current & Future Analysis for Drug Discovery Outsourcing by Therapeutic Area - Hematology, Cardiovascular, Endocrine, Gastrointestinal, Anti-Infective, Other Therapeutic Areas, Respiratory System, Pain & Anesthesia, Oncology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Latin America Historic Review for Drug Discovery Outsourcing by Therapeutic Area - Hematology, Cardiovascular, Endocrine, Gastrointestinal, Anti-Infective, Other Therapeutic Areas, Respiratory System, Pain & Anesthesia, Oncology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Latin America 15-Year Perspective for Drug Discovery Outsourcing by Therapeutic Area - Percentage Breakdown of Value Sales for Hematology, Cardiovascular, Endocrine, Gastrointestinal, Anti-Infective, Other Therapeutic Areas, Respiratory System, Pain & Anesthesia, Oncology and Ophthalmology for the Years 2012, 2021 & 2027
Latin America Recent Past, Current & Future Analysis for Drug Discovery Outsourcing by Drug Type - Small Molecules and Large Molecules (Biopharmaceuticals) - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Latin America Historic Review for Drug Discovery Outsourcing by Drug Type - Small Molecules and Large Molecules (Biopharmaceuticals) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Latin America 15-Year Perspective for Drug Discovery Outsourcing by Drug Type - Percentage Breakdown of Value Sales for Small Molecules and Large Molecules (Biopharmaceuticals) for the Years 2012, 2021 & 2027
ARGENTINA
Argentina Recent Past, Current & Future Analysis for Drug Discovery Outsourcing by Workflow - Lead Identification & Candidate Optimization, Preclinical Development, Target Validation & Functional Informatics, Target Identification & Screening and Other Workflows - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Argentina Historic Review for Drug Discovery Outsourcing by Workflow - Lead Identification & Candidate Optimization, Preclinical Development, Target Validation & Functional Informatics, Target Identification & Screening and Other Workflows Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Argentina 15-Year Perspective for Drug Discovery Outsourcing by Workflow - Percentage Breakdown of Value Sales for Lead Identification & Candidate Optimization, Preclinical Development, Target Validation & Functional Informatics, Target Identification & Screening and Other Workflows for the Years 2012, 2021 & 2027
Argentina Recent Past, Current & Future Analysis for Drug Discovery Outsourcing by Therapeutic Area - Hematology, Cardiovascular, Endocrine, Gastrointestinal, Anti-Infective, Other Therapeutic Areas, Respiratory System, Pain & Anesthesia, Oncology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Argentina Historic Review for Drug Discovery Outsourcing by Therapeutic Area - Hematology, Cardiovascular, Endocrine, Gastrointestinal, Anti-Infective, Other Therapeutic Areas, Respiratory System, Pain & Anesthesia, Oncology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Argentina 15-Year Perspective for Drug Discovery Outsourcing by Therapeutic Area - Percentage Breakdown of Value Sales for Hematology, Cardiovascular, Endocrine, Gastrointestinal, Anti-Infective, Other Therapeutic Areas, Respiratory System, Pain & Anesthesia, Oncology and Ophthalmology for the Years 2012, 2021 & 2027
Argentina Recent Past, Current & Future Analysis for Drug Discovery Outsourcing by Drug Type - Small Molecules and Large Molecules (Biopharmaceuticals) - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Argentina Historic Review for Drug Discovery Outsourcing by Drug Type - Small Molecules and Large Molecules (Biopharmaceuticals) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Argentina 15-Year Perspective for Drug Discovery Outsourcing by Drug Type - Percentage Breakdown of Value Sales for Small Molecules and Large Molecules (Biopharmaceuticals) for the Years 2012, 2021 & 2027
BRAZIL
Brazil Recent Past, Current & Future Analysis for Drug Discovery Outsourcing by Workflow - Lead Identification & Candidate Optimization, Preclinical Development, Target Validation & Functional Informatics, Target Identification & Screening and Other Workflows - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Brazil Historic Review for Drug Discovery Outsourcing by Workflow - Lead Identification & Candidate Optimization, Preclinical Development, Target Validation & Functional Informatics, Target Identification & Screening and Other Workflows Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Brazil 15-Year Perspective for Drug Discovery Outsourcing by Workflow - Percentage Breakdown of Value Sales for Lead Identification & Candidate Optimization, Preclinical Development, Target Validation & Functional Informatics, Target Identification & Screening and Other Workflows for the Years 2012, 2021 & 2027
Brazil Recent Past, Current & Future Analysis for Drug Discovery Outsourcing by Therapeutic Area - Hematology, Cardiovascular, Endocrine, Gastrointestinal, Anti-Infective, Other Therapeutic Areas, Respiratory System, Pain & Anesthesia, Oncology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Brazil Historic Review for Drug Discovery Outsourcing by Therapeutic Area - Hematology, Cardiovascular, Endocrine, Gastrointestinal, Anti-Infective, Other Therapeutic Areas, Respiratory System, Pain & Anesthesia, Oncology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Brazil 15-Year Perspective for Drug Discovery Outsourcing by Therapeutic Area - Percentage Breakdown of Value Sales for Hematology, Cardiovascular, Endocrine, Gastrointestinal, Anti-Infective, Other Therapeutic Areas, Respiratory System, Pain & Anesthesia, Oncology and Ophthalmology for the Years 2012, 2021 & 2027
Brazil Recent Past, Current & Future Analysis for Drug Discovery Outsourcing by Drug Type - Small Molecules and Large Molecules (Biopharmaceuticals) - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Brazil Historic Review for Drug Discovery Outsourcing by Drug Type - Small Molecules and Large Molecules (Biopharmaceuticals) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Brazil 15-Year Perspective for Drug Discovery Outsourcing by Drug Type - Percentage Breakdown of Value Sales for Small Molecules and Large Molecules (Biopharmaceuticals) for the Years 2012, 2021 & 2027
MEXICO
Mexico Recent Past, Current & Future Analysis for Drug Discovery Outsourcing by Workflow - Lead Identification & Candidate Optimization, Preclinical Development, Target Validation & Functional Informatics, Target Identification & Screening and Other Workflows - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Mexico Historic Review for Drug Discovery Outsourcing by Workflow - Lead Identification & Candidate Optimization, Preclinical Development, Target Validation & Functional Informatics, Target Identification & Screening and Other Workflows Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Mexico 15-Year Perspective for Drug Discovery Outsourcing by Workflow - Percentage Breakdown of Value Sales for Lead Identification & Candidate Optimization, Preclinical Development, Target Validation & Functional Informatics, Target Identification & Screening and Other Workflows for the Years 2012, 2021 & 2027
Mexico Recent Past, Current & Future Analysis for Drug Discovery Outsourcing by Therapeutic Area - Hematology, Cardiovascular, Endocrine, Gastrointestinal, Anti-Infective, Other Therapeutic Areas, Respiratory System, Pain & Anesthesia, Oncology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Mexico Historic Review for Drug Discovery Outsourcing by Therapeutic Area - Hematology, Cardiovascular, Endocrine, Gastrointestinal, Anti-Infective, Other Therapeutic Areas, Respiratory System, Pain & Anesthesia, Oncology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Mexico 15-Year Perspective for Drug Discovery Outsourcing by Therapeutic Area - Percentage Breakdown of Value Sales for Hematology, Cardiovascular, Endocrine, Gastrointestinal, Anti-Infective, Other Therapeutic Areas, Respiratory System, Pain & Anesthesia, Oncology and Ophthalmology for the Years 2012, 2021 & 2027
Mexico Recent Past, Current & Future Analysis for Drug Discovery Outsourcing by Drug Type - Small Molecules and Large Molecules (Biopharmaceuticals) - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Mexico Historic Review for Drug Discovery Outsourcing by Drug Type - Small Molecules and Large Molecules (Biopharmaceuticals) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Mexico 15-Year Perspective for Drug Discovery Outsourcing by Drug Type - Percentage Breakdown of Value Sales for Small Molecules and Large Molecules (Biopharmaceuticals) for the Years 2012, 2021 & 2027
REST OF LATIN AMERICA
Rest of Latin America Recent Past, Current & Future Analysis for Drug Discovery Outsourcing by Workflow - Lead Identification & Candidate Optimization, Preclinical Development, Target Validation & Functional Informatics, Target Identification & Screening and Other Workflows - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Latin America Historic Review for Drug Discovery Outsourcing by Workflow - Lead Identification & Candidate Optimization, Preclinical Development, Target Validation & Functional Informatics, Target Identification & Screening and Other Workflows Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of Latin America 15-Year Perspective for Drug Discovery Outsourcing by Workflow - Percentage Breakdown of Value Sales for Lead Identification & Candidate Optimization, Preclinical Development, Target Validation & Functional Informatics, Target Identification & Screening and Other Workflows for the Years 2012, 2021 & 2027
Rest of Latin America Recent Past, Current & Future Analysis for Drug Discovery Outsourcing by Therapeutic Area - Hematology, Cardiovascular, Endocrine, Gastrointestinal, Anti-Infective, Other Therapeutic Areas, Respiratory System, Pain & Anesthesia, Oncology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Latin America Historic Review for Drug Discovery Outsourcing by Therapeutic Area - Hematology, Cardiovascular, Endocrine, Gastrointestinal, Anti-Infective, Other Therapeutic Areas, Respiratory System, Pain & Anesthesia, Oncology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of Latin America 15-Year Perspective for Drug Discovery Outsourcing by Therapeutic Area - Percentage Breakdown of Value Sales for Hematology, Cardiovascular, Endocrine, Gastrointestinal, Anti-Infective, Other Therapeutic Areas, Respiratory System, Pain & Anesthesia, Oncology and Ophthalmology for the Years 2012, 2021 & 2027
Rest of Latin America Recent Past, Current & Future Analysis for Drug Discovery Outsourcing by Drug Type - Small Molecules and Large Molecules (Biopharmaceuticals) - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Latin America Historic Review for Drug Discovery Outsourcing by Drug Type - Small Molecules and Large Molecules (Biopharmaceuticals) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of Latin America 15-Year Perspective for Drug Discovery Outsourcing by Drug Type - Percentage Breakdown of Value Sales for Small Molecules and Large Molecules (Biopharmaceuticals) for the Years 2012, 2021 & 2027
MIDDLE EAST
Drug Discovery Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2022 (E)
Middle East Recent Past, Current & Future Analysis for Drug Discovery Outsourcing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
Middle East Historic Review for Drug Discovery Outsourcing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Middle East 15-Year Perspective for Drug Discovery Outsourcing by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2012, 2021 & 2027
Middle East Recent Past, Current & Future Analysis for Drug Discovery Outsourcing by Workflow - Lead Identification & Candidate Optimization, Preclinical Development, Target Validation & Functional Informatics, Target Identification & Screening and Other Workflows - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Middle East Historic Review for Drug Discovery Outsourcing by Workflow - Lead Identification & Candidate Optimization, Preclinical Development, Target Validation & Functional Informatics, Target Identification & Screening and Other Workflows Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Middle East 15-Year Perspective for Drug Discovery Outsourcing by Workflow - Percentage Breakdown of Value Sales for Lead Identification & Candidate Optimization, Preclinical Development, Target Validation & Functional Informatics, Target Identification & Screening and Other Workflows for the Years 2012, 2021 & 2027
Middle East Recent Past, Current & Future Analysis for Drug Discovery Outsourcing by Therapeutic Area - Hematology, Cardiovascular, Endocrine, Gastrointestinal, Anti-Infective, Other Therapeutic Areas, Respiratory System, Pain & Anesthesia, Oncology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Middle East Historic Review for Drug Discovery Outsourcing by Therapeutic Area - Hematology, Cardiovascular, Endocrine, Gastrointestinal, Anti-Infective, Other Therapeutic Areas, Respiratory System, Pain & Anesthesia, Oncology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Middle East 15-Year Perspective for Drug Discovery Outsourcing by Therapeutic Area - Percentage Breakdown of Value Sales for Hematology, Cardiovascular, Endocrine, Gastrointestinal, Anti-Infective, Other Therapeutic Areas, Respiratory System, Pain & Anesthesia, Oncology and Ophthalmology for the Years 2012, 2021 & 2027
Middle East Recent Past, Current & Future Analysis for Drug Discovery Outsourcing by Drug Type - Small Molecules and Large Molecules (Biopharmaceuticals) - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Middle East Historic Review for Drug Discovery Outsourcing by Drug Type - Small Molecules and Large Molecules (Biopharmaceuticals) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Middle East 15-Year Perspective for Drug Discovery Outsourcing by Drug Type - Percentage Breakdown of Value Sales for Small Molecules and Large Molecules (Biopharmaceuticals) for the Years 2012, 2021 & 2027
IRAN
Iran Recent Past, Current & Future Analysis for Drug Discovery Outsourcing by Workflow - Lead Identification & Candidate Optimization, Preclinical Development, Target Validation & Functional Informatics, Target Identification & Screening and Other Workflows - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Iran Historic Review for Drug Discovery Outsourcing by Workflow - Lead Identification & Candidate Optimization, Preclinical Development, Target Validation & Functional Informatics, Target Identification & Screening and Other Workflows Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Iran 15-Year Perspective for Drug Discovery Outsourcing by Workflow - Percentage Breakdown of Value Sales for Lead Identification & Candidate Optimization, Preclinical Development, Target Validation & Functional Informatics, Target Identification & Screening and Other Workflows for the Years 2012, 2021 & 2027
Iran Recent Past, Current & Future Analysis for Drug Discovery Outsourcing by Therapeutic Area - Hematology, Cardiovascular, Endocrine, Gastrointestinal, Anti-Infective, Other Therapeutic Areas, Respiratory System, Pain & Anesthesia, Oncology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Iran Historic Review for Drug Discovery Outsourcing by Therapeutic Area - Hematology, Cardiovascular, Endocrine, Gastrointestinal, Anti-Infective, Other Therapeutic Areas, Respiratory System, Pain & Anesthesia, Oncology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Iran 15-Year Perspective for Drug Discovery Outsourcing by Therapeutic Area - Percentage Breakdown of Value Sales for Hematology, Cardiovascular, Endocrine, Gastrointestinal, Anti-Infective, Other Therapeutic Areas, Respiratory System, Pain & Anesthesia, Oncology and Ophthalmology for the Years 2012, 2021 & 2027
Iran Recent Past, Current & Future Analysis for Drug Discovery Outsourcing by Drug Type - Small Molecules and Large Molecules (Biopharmaceuticals) - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Iran Historic Review for Drug Discovery Outsourcing by Drug Type - Small Molecules and Large Molecules (Biopharmaceuticals) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Iran 15-Year Perspective for Drug Discovery Outsourcing by Drug Type - Percentage Breakdown of Value Sales for Small Molecules and Large Molecules (Biopharmaceuticals) for the Years 2012, 2021 & 2027
ISRAEL
Israel Recent Past, Current & Future Analysis for Drug Discovery Outsourcing by Workflow - Lead Identification & Candidate Optimization, Preclinical Development, Target Validation & Functional Informatics, Target Identification & Screening and Other Workflows - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Israel Historic Review for Drug Discovery Outsourcing by Workflow - Lead Identification & Candidate Optimization, Preclinical Development, Target Validation & Functional Informatics, Target Identification & Screening and Other Workflows Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Israel 15-Year Perspective for Drug Discovery Outsourcing by Workflow - Percentage Breakdown of Value Sales for Lead Identification & Candidate Optimization, Preclinical Development, Target Validation & Functional Informatics, Target Identification & Screening and Other Workflows for the Years 2012, 2021 & 2027
Israel Recent Past, Current & Future Analysis for Drug Discovery Outsourcing by Therapeutic Area - Hematology, Cardiovascular, Endocrine, Gastrointestinal, Anti-Infective, Other Therapeutic Areas, Respiratory System, Pain & Anesthesia, Oncology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Israel Historic Review for Drug Discovery Outsourcing by Therapeutic Area - Hematology, Cardiovascular, Endocrine, Gastrointestinal, Anti-Infective, Other Therapeutic Areas, Respiratory System, Pain & Anesthesia, Oncology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Israel 15-Year Perspective for Drug Discovery Outsourcing by Therapeutic Area - Percentage Breakdown of Value Sales for Hematology, Cardiovascular, Endocrine, Gastrointestinal, Anti-Infective, Other Therapeutic Areas, Respiratory System, Pain & Anesthesia, Oncology and Ophthalmology for the Years 2012, 2021 & 2027
Israel Recent Past, Current & Future Analysis for Drug Discovery Outsourcing by Drug Type - Small Molecules and Large Molecules (Biopharmaceuticals) - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Israel Historic Review for Drug Discovery Outsourcing by Drug Type - Small Molecules and Large Molecules (Biopharmaceuticals) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Israel 15-Year Perspective for Drug Discovery Outsourcing by Drug Type - Percentage Breakdown of Value Sales for Small Molecules and Large Molecules (Biopharmaceuticals) for the Years 2012, 2021 & 2027
SAUDI ARABIA
Saudi Arabia Recent Past, Current & Future Analysis for Drug Discovery Outsourcing by Workflow - Lead Identification & Candidate Optimization, Preclinical Development, Target Validation & Functional Informatics, Target Identification & Screening and Other Workflows - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Saudi Arabia Historic Review for Drug Discovery Outsourcing by Workflow - Lead Identification & Candidate Optimization, Preclinical Development, Target Validation & Functional Informatics, Target Identification & Screening and Other Workflows Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Saudi Arabia 15-Year Perspective for Drug Discovery Outsourcing by Workflow - Percentage Breakdown of Value Sales for Lead Identification & Candidate Optimization, Preclinical Development, Target Validation & Functional Informatics, Target Identification & Screening and Other Workflows for the Years 2012, 2021 & 2027
Saudi Arabia Recent Past, Current & Future Analysis for Drug Discovery Outsourcing by Therapeutic Area - Hematology, Cardiovascular, Endocrine, Gastrointestinal, Anti-Infective, Other Therapeutic Areas, Respiratory System, Pain & Anesthesia, Oncology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Saudi Arabia Historic Review for Drug Discovery Outsourcing by Therapeutic Area - Hematology, Cardiovascular, Endocrine, Gastrointestinal, Anti-Infective, Other Therapeutic Areas, Respiratory System, Pain & Anesthesia, Oncology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Saudi Arabia 15-Year Perspective for Drug Discovery Outsourcing by Therapeutic Area - Percentage Breakdown of Value Sales for Hematology, Cardiovascular, Endocrine, Gastrointestinal, Anti-Infective, Other Therapeutic Areas, Respiratory System, Pain & Anesthesia, Oncology and Ophthalmology for the Years 2012, 2021 & 2027
Saudi Arabia Recent Past, Current & Future Analysis for Drug Discovery Outsourcing by Drug Type - Small Molecules and Large Molecules (Biopharmaceuticals) - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Saudi Arabia Historic Review for Drug Discovery Outsourcing by Drug Type - Small Molecules and Large Molecules (Biopharmaceuticals) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Saudi Arabia 15-Year Perspective for Drug Discovery Outsourcing by Drug Type - Percentage Breakdown of Value Sales for Small Molecules and Large Molecules (Biopharmaceuticals) for the Years 2012, 2021 & 2027
UNITED ARAB EMIRATES
UAE Recent Past, Current & Future Analysis for Drug Discovery Outsourcing by Workflow - Lead Identification & Candidate Optimization, Preclinical Development, Target Validation & Functional Informatics, Target Identification & Screening and Other Workflows - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
UAE Historic Review for Drug Discovery Outsourcing by Workflow - Lead Identification & Candidate Optimization, Preclinical Development, Target Validation & Functional Informatics, Target Identification & Screening and Other Workflows Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
UAE 15-Year Perspective for Drug Discovery Outsourcing by Workflow - Percentage Breakdown of Value Sales for Lead Identification & Candidate Optimization, Preclinical Development, Target Validation & Functional Informatics, Target Identification & Screening and Other Workflows for the Years 2012, 2021 & 2027
UAE Recent Past, Current & Future Analysis for Drug Discovery Outsourcing by Therapeutic Area - Hematology, Cardiovascular, Endocrine, Gastrointestinal, Anti-Infective, Other Therapeutic Areas, Respiratory System, Pain & Anesthesia, Oncology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
UAE Historic Review for Drug Discovery Outsourcing by Therapeutic Area - Hematology, Cardiovascular, Endocrine, Gastrointestinal, Anti-Infective, Other Therapeutic Areas, Respiratory System, Pain & Anesthesia, Oncology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
UAE 15-Year Perspective for Drug Discovery Outsourcing by Therapeutic Area - Percentage Breakdown of Value Sales for Hematology, Cardiovascular, Endocrine, Gastrointestinal, Anti-Infective, Other Therapeutic Areas, Respiratory System, Pain & Anesthesia, Oncology and Ophthalmology for the Years 2012, 2021 & 2027
UAE Recent Past, Current & Future Analysis for Drug Discovery Outsourcing by Drug Type - Small Molecules and Large Molecules (Biopharmaceuticals) - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
UAE Historic Review for Drug Discovery Outsourcing by Drug Type - Small Molecules and Large Molecules (Biopharmaceuticals) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
UAE 15-Year Perspective for Drug Discovery Outsourcing by Drug Type - Percentage Breakdown of Value Sales for Small Molecules and Large Molecules (Biopharmaceuticals) for the Years 2012, 2021 & 2027
REST OF MIDDLE EAST
Rest of Middle East Recent Past, Current & Future Analysis for Drug Discovery Outsourcing by Workflow - Lead Identification & Candidate Optimization, Preclinical Development, Target Validation & Functional Informatics, Target Identification & Screening and Other Workflows - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Middle East Historic Review for Drug Discovery Outsourcing by Workflow - Lead Identification & Candidate Optimization, Preclinical Development, Target Validation & Functional Informatics, Target Identification & Screening and Other Workflows Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of Middle East 15-Year Perspective for Drug Discovery Outsourcing by Workflow - Percentage Breakdown of Value Sales for Lead Identification & Candidate Optimization, Preclinical Development, Target Validation & Functional Informatics, Target Identification & Screening and Other Workflows for the Years 2012, 2021 & 2027
Rest of Middle East Recent Past, Current & Future Analysis for Drug Discovery Outsourcing by Therapeutic Area - Hematology, Cardiovascular, Endocrine, Gastrointestinal, Anti-Infective, Other Therapeutic Areas, Respiratory System, Pain & Anesthesia, Oncology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Middle East Historic Review for Drug Discovery Outsourcing by Therapeutic Area - Hematology, Cardiovascular, Endocrine, Gastrointestinal, Anti-Infective, Other Therapeutic Areas, Respiratory System, Pain & Anesthesia, Oncology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of Middle East 15-Year Perspective for Drug Discovery Outsourcing by Therapeutic Area - Percentage Breakdown of Value Sales for Hematology, Cardiovascular, Endocrine, Gastrointestinal, Anti-Infective, Other Therapeutic Areas, Respiratory System, Pain & Anesthesia, Oncology and Ophthalmology for the Years 2012, 2021 & 2027
Rest of Middle East Recent Past, Current & Future Analysis for Drug Discovery Outsourcing by Drug Type - Small Molecules and Large Molecules (Biopharmaceuticals) - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Middle East Historic Review for Drug Discovery Outsourcing by Drug Type - Small Molecules and Large Molecules (Biopharmaceuticals) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of Middle East 15-Year Perspective for Drug Discovery Outsourcing by Drug Type - Percentage Breakdown of Value Sales for Small Molecules and Large Molecules (Biopharmaceuticals) for the Years 2012, 2021 & 2027
AFRICA
Drug Discovery Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2022 (E)
Africa Recent Past, Current & Future Analysis for Drug Discovery Outsourcing by Workflow - Lead Identification & Candidate Optimization, Preclinical Development, Target Validation & Functional Informatics, Target Identification & Screening and Other Workflows - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Africa Historic Review for Drug Discovery Outsourcing by Workflow - Lead Identification & Candidate Optimization, Preclinical Development, Target Validation & Functional Informatics, Target Identification & Screening and Other Workflows Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Africa 15-Year Perspective for Drug Discovery Outsourcing by Workflow - Percentage Breakdown of Value Sales for Lead Identification & Candidate Optimization, Preclinical Development, Target Validation & Functional Informatics, Target Identification & Screening and Other Workflows for the Years 2012, 2021 & 2027
Africa Recent Past, Current & Future Analysis for Drug Discovery Outsourcing by Therapeutic Area - Hematology, Cardiovascular, Endocrine, Gastrointestinal, Anti-Infective, Other Therapeutic Areas, Respiratory System, Pain & Anesthesia, Oncology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Africa Historic Review for Drug Discovery Outsourcing by Therapeutic Area - Hematology, Cardiovascular, Endocrine, Gastrointestinal, Anti-Infective, Other Therapeutic Areas, Respiratory System, Pain & Anesthesia, Oncology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Africa 15-Year Perspective for Drug Discovery Outsourcing by Therapeutic Area - Percentage Breakdown of Value Sales for Hematology, Cardiovascular, Endocrine, Gastrointestinal, Anti-Infective, Other Therapeutic Areas, Respiratory System, Pain & Anesthesia, Oncology and Ophthalmology for the Years 2012, 2021 & 2027
Africa Recent Past, Current & Future Analysis for Drug Discovery Outsourcing by Drug Type - Small Molecules and Large Molecules (Biopharmaceuticals) - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Africa Historic Review for Drug Discovery Outsourcing by Drug Type - Small Molecules and Large Molecules (Biopharmaceuticals) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Africa 15-Year Perspective for Drug Discovery Outsourcing by Drug Type - Percentage Breakdown of Value Sales for Small Molecules and Large Molecules (Biopharmaceuticals) for the Years 2012, 2021 & 2027

PREVIEW REPORT

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com